These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1744461)

  • 1. [Disorder of serum electrolytes following CAP therapy].
    Matsuura Y; Shinohara M; Kashimura M; Baba S; Otsuka H; Okamura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1635-41. PubMed ID: 1744461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors].
    Kitada M; Sawaragi I
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):87-91. PubMed ID: 8546476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of metoclopramide and dexamethasone in preventing vomiting associated with antineoplastic chemotherapy].
    Sobkowski W; Jassem J
    Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):841-3. PubMed ID: 3684761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors].
    Yanagawa Y; Okazaki T; Okamura S; Ueki M; Sugimoto O
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2393-8. PubMed ID: 2526618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of side effects of a combination chemotherapy of cisplatin and adriamycin in gynecological malignancies: comparison between intravenous and intraarterial administration].
    Kawagoe K; Tsunoda H; Iijima S; Yokota H; Shigemitsu S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):452-7. PubMed ID: 6538404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam].
    Eguchi F; Shindo M; Emoto M; Mohtai H; Hachisuga T; Kawarabayashi T; Shirakawa K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):233-7. PubMed ID: 7857098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant chemotherapy of paclitaxel plus carboplatin in uterine corpus cancer--comparison with cisplatin, adriamycin plus cyclophosphamide].
    Tanase Y; Kawaguchi R; Haruta S; Kanayama S; Yamada Y; Kobayashi H
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):945-50. PubMed ID: 16835485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW; Coleman M; Silver RT; Ballard WP
    Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
    Perevodchikova NI; Gorbunova VA; Grigorova TM; Kozachenko VP; Marenich AF
    Vestn Akad Med Nauk SSSR; 1986; (5):8-11. PubMed ID: 3755271
    [No Abstract]   [Full Text] [Related]  

  • 14. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of metoclopramide, dexamethasone and antihistamine in the prevention of PAC chemotherapy-induced emesis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):153-9. PubMed ID: 3361170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
    Levin L; Hryniuk W
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
    Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
    Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of cepharanthin on leukopenia and thrombocytopenia caused by CDDP-ACR-CPA therapy of ovarian cancer].
    Ushiki N; Jobo T; Shimoda T; Kuramoto H; Arai M
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2701-6. PubMed ID: 3415268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.